Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan
BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) --…
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
Recorded second quarter 2025 worldwide revenue of $378.0 million, GAAP fully diluted…
